No profile data available.
Aptorum Group Limited (APM) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in London, United Kingdom, with about 1 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$1.36 million. Its market capitalization was $11.40 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
Aptorum Group reported $0 in revenue for fiscal year 2025.
$11.40 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Fluent Corp. (CNTMF), GT Biopharma, Inc. (GTBP), Aspire Biopharma Holdings, Inc. (ASBP), Theriva Biologics, Inc. (TOVX).